← Back to Search

Nicotine Replacement Therapy

Nicotine patch and lozenges for Tobacco Use

N/A

Waitlist Available

Led By Jennifer I Vidrine, PhD

Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Smoked at least 100 cigarettes in lifetime

Current smoking (defined as self-report of any smoking, even a puff, in the past 30 days)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 3 months

Awards & highlights

Study Summary

This trial will test a new smoking cessation and relapse prevention intervention for people with lung cancer.

Eligible Conditions

Tobacco Use
Lung Cancer
Smoking

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

You have smoked at least 100 cigarettes in your life.

Select...

You have smoked any amount in the past 30 days.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Completion rate of MAPS calls for UC+MAPS+RP participants - Demand

Percentage of Participants who meet inclusion criteria

Percentage of UC+MAPS+RP participants who viewed the web-based video -Demand

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Group 2: Usual Care + Motivation and Problem Solving + Relapse PreventionExperimental Treatment4 Interventions

Participants will receive brief advice to quit, an offer of enrollment to the Florida Tobacco Quitline, and a 12 week supply of nicotine replacement therapy (nicotine patches and lozenges), 6 telephone counseling sessions over 6 months, and access to a web based video.

Group II: Group 1: Usual CareActive Control2 Interventions

Participants will receive brief advice to quit, an offer of enrollment to the Florida Tobacco Quitline, and a 12 week supply of nicotine replacement therapy (nicotine patches and lozenges).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Florida Tobacco Quitline

2021

N/A

~30

Nicotine

FDA approved

Telephone counseling sessions

2021

N/A

~30

Access to a web-based video

2021

N/A

~30

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor

542 Previous Clinical Trials

135,471 Total Patients Enrolled

2 Trials studying Tobacco Use

269 Patients Enrolled for Tobacco Use

Jennifer I Vidrine, PhDPrincipal InvestigatorMoffitt Cancer Center

Vani N Simmons, PhDPrincipal InvestigatorMoffitt Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it still possible for volunteers to join this experiment?

"Indeed, this clinical trial is still open for recruitment. It was initially posted on June 7th 2021 and the latest update of its information occurred November 1st 2022."

Answered by AI

To what extent has recruitment for this clinical trial been successful?

"Affirmative. According to records on clinicaltrials.gov, this medical trial is open for enrollment; it was initially posted on June 7th 2021 and the most recent update occurred November 1st 2022. The experiment seeks 30 participants from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free

2021. "Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05362318.